SYSTEMATIC REVIEW OF MARINE SPONGE ASSOCIATED MICROBES PRODUCING LIPASE ENZYMES FOR INDUSTRIAL APPLICATIONS

Abstract

Actinomycetes are a remarkably diverse group of filamentous, Gram-positive bacteria with extensive genetic and functional capabilities, particularly noted for synthesizing a broad spectrum of secondary metabolites that have significant therapeutic, environmental, and industrial applications. These metabolites form a prolific reservoir of bioactive compounds, including antibiotics, antitumor agents, antifungals, and anthelmintics, many of which have already been developed into clinically valuable drugs and continue to serve as templates for novel therapeutics. Actinomycetes contribute an estimated 70–75% of all known microbial secondary metabolites, highlighting their central role in natural product discovery and drug development. Marine-derived actinomycetes, including genera such as Streptomyces, Salinispora, Micromonospora, and Nocardiopsis, are especially rich sources of structurally unique bioactive molecules with potent antimicrobial, anticancer, antioxidant, and antiviral properties. These organisms have adapted to extreme and nutrient-limited marine environments, producing secondary metabolites with novel modes of action that frequently differ from those isolated from terrestrial microbes. Symbiotic associations between marine sponges and actinomycetes represent a particularly valuable ecological niche, as sponge-associated bacteria often account for a substantial proportion of the host biomass and are responsible for many sponge-linked bioactive compounds. These symbionts have been shown to generate molecules exhibiting diverse pharmacological activities, including novel antimicrobial and antioxidant compounds, and are increasingly being explored for drug discovery. In addition to pharmaceuticals, marine actinomycetes are being investigated for their roles in environmental biotechnology, such as the biodegradation of pesticides, toxic metals, and other pollutants, as well as their suitability for applications in bioremediation, biofouling prevention, and waste management. This expands their utility beyond therapeutics to environmental sustainability. The enzymes produced by marine actinomycetes—including lipases, proteases, cellulases, chitinases, and other hydrolytic and oxidative enzymes—have substantial biocatalytic potential for industrial processes, such as food processing, biofuel production, detergents, agriculture, and textile manufacturing. Their ability to function under extreme conditions (e.g., high salinity, pressure, and variable temperatures) positions them as eco-friendly alternatives to traditional chemical catalysts. Emerging techniques such as genome mining, heterologous expression of biosynthetic gene clusters, and advanced cultivation strategies are enhancing our ability to discover previously "silent" secondary metabolites, thereby unveiling new chemical entities with high therapeutic and commercial value. This paper reviews the current state of knowledge regarding the applications of marine actinomycetes in applied research—with an emphasis on their bioactive metabolites, enzyme technology, ecological roles, and industrial prospects—and outlines future directions for exploration, including advanced molecular approaches and sustainable exploitation of these versatile microorganisms.